Abivax S.A. (ABVX)
NASDAQ·Healthcare·Biotechnology
$85.97
—
Mkt Cap $7.19B
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (27 analysts)
$152.71
Range $90.00 – $180.00
Implied Upside
+77.6%
Consensus $152.71 vs current $85.97
NASDAQ·Healthcare·Biotechnology
$85.97
—
Mkt Cap $7.19B
Buy
4
Hold
2
Sell
0
Price Target (27 analysts)
$152.71
Range $90.00 – $180.00
+77.6%
Consensus $152.71 vs current $85.97